Compare TMCI & PNNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TMCI | PNNT |
|---|---|---|
| Founded | 2014 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 401.8M | 423.8M |
| IPO Year | 2021 | 2007 |
| Metric | TMCI | PNNT |
|---|---|---|
| Price | $2.70 | $5.77 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 6 | 6 |
| Target Price | ★ $7.07 | $6.08 |
| AVG Volume (30 Days) | ★ 1.2M | 727.1K |
| Earning Date | 11-06-2025 | 11-24-2025 |
| Dividend Yield | N/A | ★ 16.55% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.50 |
| Revenue | ★ $218,879,000.00 | $122,377,000.00 |
| Revenue This Year | $3.25 | N/A |
| Revenue Next Year | $1.07 | N/A |
| P/E Ratio | ★ N/A | $11.57 |
| Revenue Growth | ★ 7.90 | N/A |
| 52 Week Low | $2.56 | $5.66 |
| 52 Week High | $10.79 | $7.53 |
| Indicator | TMCI | PNNT |
|---|---|---|
| Relative Strength Index (RSI) | 21.78 | 28.28 |
| Support Level | $2.56 | $5.75 |
| Resistance Level | $3.15 | $6.11 |
| Average True Range (ATR) | 0.23 | 0.16 |
| MACD | 0.05 | -0.05 |
| Stochastic Oscillator | 12.83 | 11.41 |
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.
Pennant Park Investment Corp is a closed-end, non-diversified investment company. Its investment objective is to generate current income and capital appreciation also seeking to preserve capital through debt and equity investments. The company focuses on investing in United States middle-market companies that offer attractive risk-reward to investors and to create a diversified portfolio that includes senior secured debt, mezzanine debt, and equity investments. It generates majority of its revenue from interest and dividends received from investments made.